7 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... Regimen for Multi-Drug ... Resistant Tuberculosis ... #pharmacology # ... dosing #idsa #drugs
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of Drugs ... for Treatment of ... antimicrobials #pharmacology ... #dosing #idsa # ... drugs
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Regimens for Microbiologically ... RIPE #Therapy #regimens ... #medications #pharmacology ... IDSA #Guidelines #Treatment
Aimovig (Erenumab)
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist 
Indication: Preventive Treatment of Migraines:
Dosing: 70 mg SQ monthly,
Indication: Preventive Treatment ... of Migraines: Dosing ... reported this drug ... Migraine #Neurology #Pharmacology ... #Dosing
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
recommendations on drugs ... regimen for patients ... multidrug-resistant tuberculosis ... MultiDrugResistant #Tuberculosis ... antimicrobials #pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug ... while adherent to regimen ... Eosinophils < 100 Dosing ... recommendations for the treatment ... #Indications #Pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... RAL-based ART regimen ... dosing recommendations ... Guidelines for dosing ... infections #HIVAIDS #pharmacology